← All organizations

VenatoRx Pharmaceuticals, Inc.

For profitWebsite ↗

Also known as: Venatorx Pharmaceuticals | Venatorx Pharmaceuticals, Inc. | VenatoRx Pharmaceuticals, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jan 7, 2025

Timeline

2010s

Jan 1, 2010
VenatoRx Pharmaceuticals, Inc.— Founded

Drugs by trial phase (10 distinct, 15 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 1 (7 own, 0 via acquisition)

Indications

Studied for

Recent trials (18)

NCT06733675OfficialPhase 1Jan 7, 2025
NCT06733675Lead sponsorPhase 1Jan 7, 2025
NCT06665555OfficialPhase 1Nov 4, 2024
NCT06665555Lead sponsorPhase 1Nov 4, 2024
NCT06168734OfficialPhase 3Dec 31, 2023
NCT06168734Lead sponsorPhase 3Dec 31, 2023
NCT05488678Lead sponsorPhase 1Oct 12, 2022
NCT05527834Lead sponsorPhase 1Sep 13, 2022
NCT04951505Lead sponsorPhase 1Jun 29, 2021
NCT04845321Lead sponsorPhase 1Jun 23, 2021
NCT04877379Lead sponsorPhase 1Jun 8, 2021
NCT04314206Lead sponsorPhase 1Feb 21, 2020
NCT04243863Lead sponsorPhase 1Jan 20, 2020
NCT03840148Lead sponsorPhase 3Jul 31, 2019
NCT03870490Lead sponsorPhase 1Mar 14, 2019

Details

Founded: Malvern, PA, US Jan 1, 2010
Last known activity: Jan 7, 2025